Price control, ad-hoc regulatory changes and new policies may hamper pharma sector growth: Pfizer
The Indian pharma market (IPM) stood at Rs 121,833 crore at the end of the financial year 2018, growing at 6.3 percent over the last 12 months period
The post Price control, ad-hoc regulatory changes and new policies may hamper pharma sector growth: Pfizer appeared first on Firstpost.
from Firstpost https://ift.tt/2PuUK5s
via IFTTT